Biotechnology: The Key To America's Next Manufacturing Revolution

By Heidi Wagner, Global Head of Government Affairs, and Mike Paglia, Chief Operating Officer, ElevateBio BaseCamp

Over the last several decades, cell and gene therapies (CGTs) have emerged as efficacious solutions to address diseases for which there are no available treatments and as such, investment has skyrocketed into these highly innovative medicines. However, while the discovery and development of CGTs have significantly advanced, biomanufacturing has not evolved at the same pace. It continues to rely mainly on traditional modes of development or a patchwork of technologies and providers, slowing the impact on human health.

Establishing innovative manufacturing practices, building cutting-edge facilities, and developing the skilled labor force needed to manufacture these life-changing medicines are crucial steps for realizing the potential of advanced therapeutics. ElevateBio is planning to expand its cGMP manufacturing and process development business, BaseCamp, to Pittsburgh in a bid to revitalize the American manufacturing sector. This expansion will enable more biopharmaceutical firms to translate cutting-edge science and research into practical applications. Discover how biomanufacturing holds the potential to transform manufacturing in the U.S. and review the key role it plays in accelerating access to technologies and expertise that could revolutionize medicine.